Doojduen Villaluna

Dexrazoxane-Associated Risk for Acute Myeloid Leukemia/Myelodysplastic Syndrome and Other Secondary Malignancies in Pediatric Hodgkin's Disease

Cameron K. Tebbi, Wendy B. London, Debra L. Friedman et al. · Journal of Clinical Oncology · 2007 · 480 citations · Full text

Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group

Javier G. Blanco, Can-Lan Sun, Wendy Landier et al. · Journal of Clinical Oncology · 2011 · 362 citations · Full text

EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment

Jeremy Whelan, Stefan Bielack, Neyssa Marina et al. · Annals of Oncology · 2014 · 321 citations · Full text

Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial

David R. Freyer, Lu Chen, Mark Krailo et al. · The Lancet Oncology · 2016 · 242 citations · Full text

Oncology, Medicine, Metronomic Therapy +4

A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425

Cindy L. Schwartz, Louis S. Constine, Doojduen Villaluna et al. · Blood · 2009 · 209 citations · Full text